Charles River offers preclinical cardiac risk assessment services together with industry-leading expertise. Offerings range from GLP hERG and action potential duration (ADP) assays, which are recommended for candidate selection and IND submissions, to a comprehensive survey of cardiac ion channels and cardiomyocyte assays. Our services provide insight into potential cardiac risk and aid in effective decision-making in early preclinical development.

I need to...